Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet Dermatol ; 23(6): 465-e88, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23140313

RESUMO

BACKGROUND: Canine leproid granuloma (CLG) characteristically presents as single to multiple circumscribed dermal to subcutaneous nodules in haired skin. An unidentified mycobacterium is considered be the aetiological agent of this entity. ANIMALS: Several cases of canine leproid granulomas occurred in dogs in New Zealand during 2010 and 2011. Cases appeared in clusters, affecting multiple closely related foxhounds domiciled in the same kennels. All affected hounds recovered after topical and/or systemic antimicrobial therapy. Two similar outbreaks that occurred in foxhounds near Melbourne, Australia are also reported. METHODS: Cases were investigated using cytological, histological, microbiological and several molecular techniques. An environmental epidemiological study was also performed. RESULTS: A diagnosis of CLG was established in 11 dogs. Molecular identification of the causative agent confirmed that it was a mycobacterial species with 100% sequence homology within the amplified regions of the 16S rRNA gene and internal transcribed spacer (ITS1) with that found in association with similar infections from the USA, Brazil and Australia. CONCLUSION AND CLINICAL IMPORTANCE: This report details the first occurrence of multiple cases of CLG occurring in in-contact dogs and the first proven case of CLG in dogs in New Zealand.


Assuntos
Doenças do Cão/patologia , Granuloma/veterinária , Infecções por Mycobacterium/veterinária , Dermatopatias Bacterianas/veterinária , Animais , Austrália/epidemiologia , Doenças do Cão/tratamento farmacológico , Doenças do Cão/epidemiologia , Cães , Granuloma/tratamento farmacológico , Granuloma/epidemiologia , Granuloma/patologia , Infecções por Mycobacterium/tratamento farmacológico , Infecções por Mycobacterium/epidemiologia , Infecções por Mycobacterium/patologia , Nova Zelândia/epidemiologia , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/epidemiologia , Dermatopatias Bacterianas/patologia
2.
J Bacteriol ; 187(7): 2267-77, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15774869

RESUMO

The unusual and complex cell wall of pathogenic mycobacteria plays a major role in pathogenesis, with specific complex lipids acting as defensive, offensive, or adaptive effectors of virulence. The phthiocerol and phthiodiolone dimycocerosate esters (PDIMs) comprise one such category of virulence-enhancing lipids. Recent work in several laboratories has established that the Mycobacterium tuberculosis fadD26-mmpL7 (Rv2930-Rv2942) locus plays a major role in PDIM biosynthesis and secretion and that PDIM is required for virulence. Here we describe two independent transposon mutants (WAg533 and WAg537) of Mycobacterium bovis, both of which carry an insertion in Mb0100 (= M. tuberculosis Rv0097) to reveal a new locus involved in PDIM biosynthesis. The mutations have a polar effect on expression of the downstream genes Mb0101, Mb0102 (fadD10), Mb0103, and Mb0104 (nrp), and Mb0100 is shown to be in an operon comprising these genes and Mb0099. Reverse transcription-PCR analysis shows elevated transcription of genes in the operon upstream from the transposon insertion sites in both mutants. Both mutants have altered colony morphology and do not synthesize PDIMs or glycosylphenol-PDIM. Both mutants are avirulent in a guinea pig model of tuberculosis, and when tested as a vaccine, WAg533 conferred protective immunity against M. bovis infection at least equal to that afforded by M. bovis bacillus Calmette-Guerin.


Assuntos
Elementos de DNA Transponíveis/fisiologia , Lipídeos/biossíntese , Mutagênese Sítio-Dirigida/imunologia , Mycobacterium bovis/genética , Mycobacterium bovis/metabolismo , Vacinas contra a Tuberculose/imunologia , Animais , Vacina BCG/imunologia , Elementos de DNA Transponíveis/genética , Expressão Gênica , Cobaias , Mycobacterium bovis/imunologia , Mycobacterium bovis/patogenicidade , Tuberculose/prevenção & controle , Vacinas contra a Tuberculose/genética , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...